Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivityFederica D’Antonio, Armando Santoro, Annarita Destro et al.|Medicine|2019Cited by 12
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumabRita De Sanctis, Armando Santoro, Laura Giordano et al.|The Breast|2021Cited by 10
Real-life data on the cardiac toxicity of adjuvant fixed-dose subcutaneous trastuzumab in HER2-positive breast cancerRita De Sanctis, Armando Santoro, Rosalba Torrisi et al.|Annals of Oncology|2018Cited by 1